A three-stage Yb-fiber amplifier emitted 1.43 kW of single-mode power when seeded with a 25 GHz linewidth master oscillator (MO). The amplified output was polarization stabilized and phase locked using active heterodyne phase control. A low-power sample of the output beam was coherently combined to a second fiber amplifier with 90% visibility. The measured combining efficiency agreed with estimated decoherence effects from fiber nonlinearity, linewidth, and phase-locking accuracy. This is the highest-power fiber laser that has been coherently locked using any method that allows brightness scaling.
Applications requiring long-range atmospheric propagation are driving the development of high-power thulium fiber lasers. We report on the performance of two different laser configurations for high-power tunable thulium fiber lasers: one is a single oscillator utilizing a volume Bragg grating for wavelength stabilization; the other is a master oscillator power amplifier system with the oscillator stabilized and made tunable by a diffraction grating. Each configuration provides >150 W of average power, >50% slope efficiency, narrow output linewidth, and >100 nm tunability in the wavelength range around 2 μm.
Lowest-order, single-mode laser oscillation is reported in gain-guided index-antiguided fiber lasers having core diameters from 100 to 400 microm. A model is presented explaining how to select resonator mirrors to assure single-mode operation.
Experimental demonstration is presented of lasing in a gain-guided index antiguided Nd 3+ -doped phosphate glass core fiber. This type of lasing remains in its lowest-order mode even when pumped well above threshold, leading to excellent beam quality.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.